---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-145741"
form_type: "8-K"
ticker: "VRDN"
cik: "0001590750"
company_name: "Viridian Therapeutics, Inc.\\DE"
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:33:45.354946+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Viridian shareholders approve 8M-share increase in equity plan in close vote

## Summary
- Stockholders narrowly approved amendment to increase equity plan shares by 8,000,000 (35.3M for, 35.1M against).
- Three Class I directors elected: Jeff Ajer, Chris Cain, Sarah Gheuens.
- Ratification of KPMG as auditor, advisory say-on-pay, and 2025 ESPP all passed.
- Close 49.8% opposition on equity plan reflects significant shareholder dissent.

## SEC filing metadata
- accession: 0001193125-25-145741
- form_type: 8-K
- ticker: VRDN
- cik: 0001590750
- company_name: Viridian Therapeutics, Inc.\DE
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590750/000119312525145741/0001193125-25-145741-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590750/000119312525145741/d871650d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-145741
- JSON: https://secwatch.observer/filing/0001193125-25-145741.json
- Plain text: https://secwatch.observer/filing/0001193125-25-145741.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.